RETRIEVE-AMI Study

NACompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

May 6, 2022

Primary Completion Date

October 24, 2024

Study Completion Date

May 28, 2025

Conditions
Myocardial InfarctionThrombusCoronary Artery Disease
Interventions
DEVICE

Retriever Thrombectomy

The SolitaireTM X revascularisation device is a self-expanding stent designed for dynamic clot integration with radiopaque markers that enhance visualisation of the optimal working length. After a thrombotic occlusion has been identified and crossed with a guidewire, the stent-retriever thrombectomy proceeds. A microcatheter (e.g., PhenomTM, MarksmanTM) is advanced over the guidewire and once it has traversed the thrombotic occlusion, the SolitaireTM X device is advanced through the microcatheter until the usable length of the stent extends past each side of the thrombus in the vessel. As the microcatheter is retracted to the proximal radiopaque marker of the stent, the stent self-expands and entangles the thrombus. The microcatheter and SolitaireTM X Revascularisation Device are withdrawn as a unit into the guide catheter under continuous aspiration. PCI then proceeds driven by clinical decision making and department guidelines.

PROCEDURE

Percutaneous Coronary Intervention

Standard of care

PROCEDURE

Thrombus Aspiration

Standard of care treatment with manual thrombectomy catheter

Trial Locations (1)

OX3 9DU

Oxford Heart Centre, Oxford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

collaborator

Terumo Corporation

INDUSTRY

lead

Oxford University Hospitals NHS Trust

OTHER